The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Liver fibrosis
Abstract
Liver damage leads to an inflammatory response and to the activation and proliferation of mesenchymal cell populations within the liver which remodel the extracellular matrix as part of an orchestrated wound-healing response. Chronic damage results in a progressive accumulation of scarring proteins (fibrosis) that, with increasing severity, alters tissue structure and function, leading to cirrhosis and liver failure. Efforts to modulate the fibrogenesis process have focused on understanding the biology of the heterogeneous liver fibroblast populations. The fibroblasts are derived from sources within and outwith the liver. Fibroblasts expressing α-smooth muscle actin (myofibroblasts) may be derived from the transdifferentiation of quiescent hepatic stellate cells. Other fibroblasts emerge from the portal tracts within the liver. At least a proportion of these cells in diseased liver originate from the bone marrow. In addition, fibrogenic fibroblasts may also be generated through liver epithelial (hepatocyte and biliary epithelial cell)–mesenchymal transition. Whatever their origin, it is clear that fibrogenic fibroblast activity is sensitive to (and may be active in) the cytokine and chemokine profiles of liver-resident leucocytes such as macrophages. They may also be a component driving the regeneration of tissue. Understanding the complex intercellular interactions regulating liver fibrogenesis is of increasing importance in view of predicted increases in chronic liver disease and the current paucity of effective therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–230 of 230
Poo, J. L., Feldmann, G., Erlinger, S., Braillon, A., Gaudin, C., Dumont, M., & Lebrec, D. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91739-q · Cited by 62
Establishment of an Immortalized Human Hepatic Stellate Cell Line to Develop Antifibrotic Therapies
Shibata, N., Watanabe, T., Okitsu, T., Sakaguchi, M., Takesue, M., Kunieda, T., Omoto, K., Yamamoto, S., Tanaka, N., & Kobayashi, N. (2003) · Cell Transplantation · doi:10.3727/000000003108747064 · Cited by 62
Pathogenesis of Primary Biliary Cirrhosis
Jones, D. E. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.004 · Cited by 62
Gliotoxin non‐selectively induces apoptosis in fibrotic and normal livers
Hagens, W. I., Olinga, P., Meijer, D. K. F., Groothuis, G. M. M., Beljaars, L., & Poelstra, K. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01212.x · Cited by 60
An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver
Mancini, R., Benedetti, A., & Jézéquel, A. M. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00197389 · Cited by 58
Effects of long-term administration of interferon α in two models of liver fibrosis in rats
Fort, J., Pilette, C., Veal, N., Oberti, F., Gallois, Y., Douay, O., Rosenbaum, J., & Calès, P. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80012-3 · Cited by 57
Resolving fibrosis in the diseased liver: Translating the scientific promise to the clinic
Muddu, A. K., Guha, I. N., Elsharkawy, A. M., & Mann, D. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.006 · Cited by 55
Louis, H., Moine, A. L., Quertinmont, E., Peny, M.-O., Geerts, A. E., Goldman, M., Moine, O. L., & Deviere, J. M. E. (2000) · Hepatology · doi:10.1002/hep.510310218 · Cited by 55
Sakaida, I., Uchida, K., Matsumura, Y., & Okita, K. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80322-x · Cited by 52
Contribution of immune response to the hepatic fibrosis induced by porcine serum
Bhunchet, E., Eishi, Y., & Wake, K. (1996) · Hepatology · doi:10.1002/hep.510230423 · Cited by 50
Dilger, K., Denk, A., Heeg, M. H. J., & Beuers, U. H. (2005) · Hepatology · doi:10.1002/hep.20568 · Cited by 48
Gao, R., McCormick, C. J., Arthur, M. J. P., Ruddell, R. G., Oakley, F., Smart, D. E., Murphy, F. R., Harris, M., & Mann, D. A. (2002) · Liver International · doi:10.1046/j.0106-9543.2001.01555.x · Cited by 47
Immunocytochemical localization of type B collagen: a component of basement membrane in human liver.
Biempica, L., Morecki, R., Wu, C. H., Giambrone, M. A., & Rojkind, M. (1980) · PubMed · Cited by 45
Guérret, S., Desmoulière, A., Chossegros, P., Costa, A. M. A., Badid, C., TREPO, C. G., Grimaud, J.-A., & Chevallier, M. (1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.00148.x · Cited by 45
Activation, isolation, identification and in vitro proliferation of oval cells from adult rat livers
He, Z., Tan, W., Tang, Y. F., Zhang, H. J., & Feng, M. (2004) · Cell Proliferation · doi:10.1111/j.1365-2184.2004.00293.x · Cited by 43
Sauvant, P., Sapin, V., Abergel, A., Schmidt, C. K., Blanchon, L., Alexandre-Gouabau, M. C., Rosenbaum, J., Bommelaer, G., Rock, E., Dastugue, B., et al. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00023-7 · Cited by 43
Kono, H., Bradford, B. U., Rusyn, I., Fujii, H., Matsumoto, Y., Yin, M., & Thurman, R. G. (2000) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340070034 · Cited by 39
Kono, T., Shimoda, M., Takahashi, M., Matsumoto, K., Yoshimoto, T., Mizutani, M., Tabata, C., Okoshi, K., Wada, H., & Kubo, H. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.501 · Cited by 37
Verrill, C. L., Davies, J., Millward‐Sadler, H., Sundström, L., & Sheron, N. (2002) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(03)00042-x · Cited by 35
Population Screening in Hereditary Hemochromatosis
Motulsky, A. G., & Beutler, E. (2000) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.21.1.65 · Cited by 35
Leucine stimulates HGF production by hepatic stellate cells through mTOR pathway
Tomiya, T., Nishikawa, T., Inoue, Y., Ohtomo, N., Ikeda, H., Tejima, K., Watanabe, N., Tanoue, Y., Omata, M., & Fujiwara, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.093 · Cited by 31
Abriss, B., Hollweg, G., Gressner, A. M., & Weiskirchen, R. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00361-6 · Cited by 29
Kariv, R., den Enden, A. H.-V., Zvibel, I., Rosner, G., Brill, S., Shafritz, D., Halpern, Z., & Oren, R. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.00827.x · Cited by 28
Palmer, J. M., Robe, A. J., Burt, A. D., Kirby, J. A., & Jones, D. E. (2004) · Hepatology · doi:10.1002/hep.20248 · Cited by 25
Self-citationKinoshita, K., Iimuro, Y., Fujimoto, J., Inagaki, Y., Namikawa, K., Kiyama, H., Nakajima, Y., Otogawa, K., Kawada, N., Friedman, S. L., et al. (2006) · Gut · doi:10.1136/gut.2005.085704 · Cited by 23
Ueno, Y., Moritoki, Y., Shimosegawa, T., & Gershwin, M. E. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2019-y · Cited by 22
Liver involvement in cystic fibrosis
Brigman, C., & Feranchak, A. P. (2006) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-006-0005-8 · Cited by 21
A Diagnostic Approach to Hemochromatosis
Tavill, A. S., & Adams, P. C. (2006) · Canadian Journal of Gastroenterology · doi:10.1155/2006/934098 · Cited by 19
Guo, L., Enzan, H., Hayashi, Y., Miyazaki, E., Jin, Y., Toi, M., Kuroda, N., & Hiroi, M. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.07.006 · Cited by 19
Current Therapy of Chronic Hepatitis B
Pardo, M., Bartolomé, J., & Carréño, V. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.12.013 · Cited by 8
Cited by
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Järveläinen, H., Sainio, A., Koulu, M., Wight, T. N., & Penttinen, R. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001289 · Cited by 566
Ju, C., & Tacke, F. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.104 · Cited by 554
Lee, K.-P., Lee, J.-H., Kim, T.-S., Kim, T.-H., Park, H.-D., Byun, J.-S., Kim, M.-C., Jeong, W.-I., Calvisi, D. F., Kim, J.-M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912203107 · Cited by 493
Redox Control of the Cell Cycle in Health and Disease
Sarsour, E. H., Kumar, M. G., Chaudhuri, L., Kalen, A. L., & Goswami, P. C. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2513 · Cited by 381
Metadata
- Authors
- Wallace, K., Burt, A. D., & Wright, M. C.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2008-03-13
- Volume
- 411
- Issue
- 1
- Pages
- 1-18
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W4211047743
- Cited by
- 262
- References
- 230
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.